Notice NOT-OD-20-058 from the NIH Guide for Grants and Contracts

Competitive Salary: EMBL: Senior Java Developer (FIRE) Location: Cambridge, Cambridgeshire, England

3+ years of professional experience in project-oriented, strategic analysis roles such as management consulting, investment banking, or other professional…
From Adaptive Biotechnologies - Tue, 21 Jan 2020 21:07:14 GMT - View all Seattle, WA jobs

3+ years of professional experience in project-oriented, strategic analysis roles such as management consulting, investment banking, or other professional…
From Adaptive Biotechnologies - Tue, 21 Jan 2020 21:07:14 GMT - View all Seattle, WA jobs

Notice NOT-HL-19-747 from the NIH Guide for Grants and Contracts

Funding Opportunity RFA-NS-20-028 from the NIH Guide for Grants and Contracts. The purpose of this Funding Opportunity Announcement (FOA) is to solicit cooperative agreement applications that propose clinical trials to test the comparative effectiveness of existing pharmacological therapies or devices for prevention or management of pain while reducing risk of addiction. The studies must evaluate methods to manage specific pain conditions that are within the mission and research interests of participating NIH Institutes and Centers, and evaluate interventions including medications, biologics, medical and assistive devices or delivery system strategies in controlled trials. This FOA does not include testing behavioral interventions for management of pain. The overall goal is to inform clinicians about the effectiveness of pharmacological or device interventions or management strategies concerning use of these interventions that reduce opioid use, improve functional outcomes and reduce pain for diseases or conditions of interest. Clinical trials will be conducted within the infrastructure of the HEAL Pain Effectiveness Research Network.

Funding Opportunity RFA-DK-19-034 from the NIH Guide for Grants and Contracts. The George M. O'Brien Urology Research Centers (U54) and Exploratory Centers for Interdisciplinary Research in Benign Urology (P20) serve to advance the NIDDKs mission to support highly meritorious, innovative, interdisciplinary research in benign urologic diseases and disorders, and the training of the next generation of researchers. Critical to these broad goals is the ability to promote productive interactions between the U54 and P20 Centers, the institutional career development programs (K12), and the broader urology research and clinical communities. The purpose of this Funding Opportunity Announcement (FOA) is to solicit applications for a new Urology Centers Program Interactions Core (U24). The Interactions Core will serve as focal point for establishing productive collaborations within the Urology Centers Programs and between these Programs and other NIDDK urology training and scientific efforts and the broader research and clinical communities.

Orion Corporation: Orion Corporation operates in more than 20 countries, where we Orionees, 3200 in total, work in all kinds of positions. Among us there are R Finland (FI)

£31,897 to £39,986: Wellcome Sanger Institute: Postdoctoral Fellow - CRISPR screening and QTL mapping in neurodegeneration #{%22news%22:{}}">Genome Wellcome Campus. We hold an Athena SWAN Bron Hinxton, Cambridgeshire, England

Notice NOT-DE-20-007 from the NIH Guide for Grants and Contracts

To apply, provide a CV, a cover letter highlighting research interests and expertise, and the names and contact information for three references.
From Marquette University - Fri, 17 Jan 2020 16:22:49 GMT - View all Milwaukee, WI jobs

Competitive with benefits, subject to skills and experience: The Francis Crick Institute: We seek a talented and motivated postdoc to join Nick Luscombe’s Laboratory of Bioinformatics & Computational Biology. London (Greater) (GB)

£31,897 to £39,986: Wellcome Sanger Institute: Postdoctoral Fellow - CRISPR screening and QTL mapping in neurodegeneration #{%22news%22:{}}">Genome Wellcome Campus. We hold an Athena SWAN Bron Hinxton, Cambridgeshire, England

Funding Opportunity RFA-TR-20-002 from the NIH Guide for Grants and Contracts. This Limited Competition Funding Opportunity Announcement (FOA) invites an application from the currently funded Microphysiological Systems (MPS) Database Center (MPS DC) which supports the NIH Tissue Chip Consortium. The overall goal of the MPS DC is to integrate the efforts of all funded components of the Tissue Chip Consortium and serve as a community-wide resource for deposition of tissue chip data, standards, protocols, and analytical tools. The MPS DC is expected to continue to be the central clearinghouse for tissue chips data management, and to incorporate novel approaches and technologies for data management, data mining and meta-analyses, and data sharing across many organs and tissues, diseases, data types, and tissue chip platforms. The MPS DC is expected to provide different levels of public and tiered access to tissue chip information for basic and clinical researchers, academic and practicing physicians, the pharmaceutical industry, NIH, FDA and other government agencies, patients, and the lay public. The MPS DC will work with IQ Consortium members to develop and make available a secure, customizable coordinated data management system for collection, storage, and analyses of diverse data types from multiple tissue chip platforms being developed and used for drug screening, safety and efficacy testing. The application must include a clear and well laid out plan to be completely independent and self-sustaining before the end of the requested NIH support.

Notice NOT-OD-20-055 from the NIH Guide for Grants and Contracts

Funding Opportunity PAR-20-097 from the NIH Guide for Grants and Contracts. This funding opportunity announcement is designed to support biomedical knowledgebases. Biomedical knowledgebases under this announcement should have the primary function to extract, accumulate, organize, annotate, and link growing bodies of information related to core datasets. Support for data curation should include efficient and effective methods of curation that scale to the needs of community and include semi-automated methods. Support for software and tool development must be limited to that which provides essential functions or significantly increases the efficiency of operation of the knowledgebase. Applications that have a significant focus on software and tool development are not appropriate for this activity.

Funding Opportunity PAR-20-089 from the NIH Guide for Grants and Contracts. This funding opportunity announcement is designed to support biomedical data repositories. Biomedical data repositories under this announcement should have the primary function to ingest, archive, preserve, manage, distribute, and make accessible the data related to a particular system or systems. Support for data curation must be limited to that which improves the efficiency and accessibility of data ingestion, management, and use and reuse by the user communities. Support for software and tool development must be limited to that which provides essential functions or significantly increases the efficiency of operation of the repository. Applications that have a significant focus on software and tool development are not appropriate for this activity.

Orion Corporation: Orion Corporation operates in more than 20 countries, where we Orionees, 3200 in total, work in all kinds of positions. Among us there are R Finland (FI)

Notice NOT-CA-20-024 from the NIH Guide for Grants and Contracts

Notice NOT-DK-20-004 from the NIH Guide for Grants and Contracts